Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
PERK Dependent Activation of JAK1 and STAT3 Contributes to ER Stress Induced Inflammation.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.
Plasma biomarkers discriminate clinical forms of multiple sclerosis.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
[Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro].
Vitamin D levels in Hispanics with multiple sclerosis.
Anti-CD25 Immunotherapy: Regulating the Regulators.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
The Contributions of Solar Ultraviolet Radiation Exposure and Other Determinants to Serum 25-Hydroxyvitamin D Concentrations in Australian Adults: The AusD Study.
Concurrent motor and cognitive function in multiple sclerosis: a motor overflow and motor stability study.
Barriers to investigator-initiated deep brain stimulation and device research.
The role of iron in brain ageing and neurodegenerative disorders.
Imaging multiple sclerosis and other neurodegenerative diseases.
Jekyll and Hide: The two faces of amyloid β.
Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death.
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.
Pages
« first
‹ previous
…
275
276
277
278
279
280
281
282
283
…
next ›
last »